Evolution of anti-viral and anti-tumor immunity in tumors in response to oncolytic virus therapy

被引：0
|
作者：
Lyudovyk, Olga
Burman, Bharat
Ceglia, Nicholas
Greenbaum, Benjamin
Elhanati, Yuval
Zamarin, Dmitriy
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-LB400
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB400
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The 16th International Oncolytic Virus Conference: Advancing oncolytic virotherapy by balancing anti-tumor and anti-viral immunity
    Stavrakaki, Eftychia
    Everts, Anne
    van den Hoogen, Bernadette G.
    Lamfers, Martine L. M.
    MOLECULAR THERAPY ONCOLOGY, 2025, 33 (01):
  • [2] Defining the balance of anti-viral and anti-tumor T cell responses to oncolytic virus therapy using single cell approaches
    Burman, Bharat
    Ceglia, Nicholas
    Hirschhorn, Daniel
    Budhu, Sadna
    Mangarin, Levi
    Oseledchyk, Anton
    Bykov, Yonina
    McPherson, Andrew
    Shah, Sohrab
    Wolchok, Jedd
    Merghoub, Taha
    Zamarin, Dmitriy
    CANCER RESEARCH, 2022, 82 (12)
  • [3] Herpes Oncolytic Virus Elicits Greater Anti-Tumor Immunity
    Nakao, A.
    Yamamura, K.
    Takeda, S.
    Nomoto, S.
    Sahin, T.
    Kanzaki, A.
    Sugimoto, H.
    Shirota, T.
    Kodera, Y.
    Kasuya, H.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1488 - 1488
  • [4] Harnessing oncolytic virus-mediated anti-tumor immunity
    Schirrmacher, Volker
    Fournier, Philippe
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [5] NANOPARTICLE TREATMENT REBALANCES IMMUNODOMINANCE OF ANTI-VIRUS IMMUNITY TO ENHANCE ANTI-TUMOR IMMUNITY DURING ONCOLYTIC ADENOVIRUS THERAPY IN SOLID TUMORS.
    Shin, Dong Ho
    Jiang, Hong
    Gillard, Andrew
    Kim, Debora
    Nguyen, Teresa
    Fan, Xuejun
    Yi, Yanhua
    Ban, Kechen
    Alemany, Ramon
    Alonso, Marta M.
    Lang, Frederick
    Gomez-Manzano, Candelaria
    Ozpolat, Bulent
    Fueyo, Juan
    NEURO-ONCOLOGY, 2022, 24 : 139 - 140
  • [6] ONCOLYTIC ADENOVIRUS THERAPY OF MALIGNANT GLIOMA IN IMMUNE COMPETENT MICE INDUCES ANTI-VIRAL AND ANTI-TUMOR IMMUNE RESPONSES
    Kleijn, A.
    Kloezeman, J. J.
    Treffers-Westerlaken, E. J.
    Leenstra, S.
    Dirven, C. M. F.
    Debets, R.
    Lamfers, M. M. L.
    NEURO-ONCOLOGY, 2012, 14 : 23 - 23
  • [7] Combining the Anti-Viral and Anti-Tumor CD8+T Cell Response Facilitates Immune Checkpoint Blockade Therapy and Oncolytic Virotherapy
    Sangsuwannukul, Thanich
    Kendall, Benjamin
    Webb, Mason J.
    Vloten, Jacob V.
    Evgin, Laura
    Tonne, Jason M.
    Thompson, Jill
    Metko, Muriel
    Moore, Madelyn
    Yerovi, Maria P. Chiriboga
    McNiven, Mark
    Singh, Monga Satdarshan Pal
    Borad, Mitesh
    Lewis, Roberts R.
    Vile, Richard G.
    MOLECULAR THERAPY, 2024, 32 (04) : 123 - 124
  • [8] INTERFERON AS AN ANTI-VIRAL AND ANTI-TUMOR THERAPEUTIC AGENT
    ARVIN, AM
    OPHTHALMOLOGY, 1980, 87 (12) : 1236 - 1238
  • [9] Oncolytic Vaccinia Virus Armed with GM-CSF: Studies on Safety, Efficacy, Anti-Viral and Anti-Tumor Immune Response in Immunocompetent and Immunodeficient Rodents
    Parviainen, Suvi T.
    Ahonen, Marko
    Diaconu, Iulia
    Pesonen, Sari
    Hemminki, Akseli
    Cerullo, Vincenzo
    MOLECULAR THERAPY, 2012, 20 : S273 - S273
  • [10] Oncolytic HSV Vectors and Anti-Tumor Immunity
    Glorioso, Joseph C.
    Cohen, Justus B.
    Goins, William F.
    Hall, Bonnie
    Jackson, Joseph W.
    Kohanbash, Gary
    Amankulor, Nduka
    Kaur, Balveen
    Caligiuri, Michael A.
    Chiocca, E. Antonio
    Holland, Eric C.
    Queva, Christophe
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2021, 41 : 381 - 468
12345